Skip to content

PHARMACIE DELVA: what changed

BE 1011.467.302NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€26,436
2024 · €14,977+€11,459
Equity
€51,413
2024 · €24,977+€26,436
Cash
€65,060
2024 · €107,525-€42,466
Balance sheet total
€437,107
2024 · €481,212-€44,105

Largest movements

2024 to 2025
Assets
  • Cash -€42,466

    down €42,466 (-39.5%), from €107,525 to €65,060

    mainly Debts after one year (-€30,510) and Other debts (-€20,000)

  • Stocks and contracts +€19,213

    up €19,213 (+14.6%), from €131,823 to €151,035

  • Intangible fixed assets -€14,000

    down €14,000 (-10.4%), from €134,148 to €120,148

  • Tangible fixed assets -€13,349

    down €13,349 (-31.0%), from €43,033 to €29,684

  • Receivables within one year +€10,649

    up €10,649 (+256%), from €4,166 to €14,814

    of which Other amounts receivable: +€11,058

Equity and liabilities
  • Debts after one year -€30,510

    down €30,510 (-10.1%), from €300,847 to €270,337

  • Profit (loss) carried forward +€26,436

    up €26,436 (+177%), from €14,977 to €41,413

  • Other debts -€20,000

    down €20,000 (-50.8%), from €39,340 to €19,340

  • Trade debts -€13,500

    down €13,500 (-17.4%), from €77,690 to €64,190

  • Tax, wage and social debts -€6,205

    down €6,205 (-84.6%), from €7,334 to €1,129

    of which Taxes: -€6,254

Income statement
  • Gross operating margin +€55,844

    up €55,844 (+114%), from €48,991 to €104,836

  • Depreciation +€18,302

    up €18,302 (+131%), from €13,925 to €32,227

  • Financial charges +€12,465

    up €12,465 (+189%), from €6,580 to €19,045

  • Staff costs +€11,624

    up €11,624 (+155%), from €7,487 to €19,111

  • Taxes +€2,132

    up €2,132 (+38.9%), from €5,485 to €7,617

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result.

Result 2024 €14,977
Gross operating margin +€55,844
Staff costs -€11,624
Depreciation -€18,302
Other operating charges +€138
Financial charges -€12,465
Taxes -€2,132
Result 2025 €26,436
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations -€9,450
Investment -€3,490
Financing -€29,525
Cash 2024 €107,525
Net result for the year +€26,436
Depreciation +€32,227
Stocks and contracts -€19,213
Receivables within one year -€10,649
Deferred charges and accrued income +€2,765
Trade debts -€13,500
Tax, wage and social debts -€6,205
Other debts -€20,000
Accrued charges and deferred income -€1,312
Investment in fixed assets (net) -€3,490
Debts after one year -€30,510
Current portion of long-term debt +€985
Cash 2025 €65,060
brings cash intakes cash out
Every line side by side 42 lines
Line Code 2024 2025 Change %
Total assets 20/58 €481,212 €437,107 -€44,105 -9.2%
Formation expenses 20 €1,387 €0 -€1,387 -100%
Fixed assets 21/28 €177,546 €150,197 -€27,349 -15.4%
Intangible fixed assets 21 €134,148 €120,148 -€14,000 -10.4%
Tangible fixed assets 22/27 €43,033 €29,684 -€13,349 -31.0%
Furniture and vehicles 24 €43,033 €29,684 -€13,349 -31.0%
Financial fixed assets 28 €365 €365 = 0.0%
Current assets 29/58 €302,279 €286,910 -€15,369 -5.1%
Stocks and contracts in progress 3 €131,823 €151,035 +€19,213 +14.6%
Stocks 30/36 €131,823 €151,035 +€19,213 +14.6%
Amounts receivable within one year 40/41 €4,166 €14,814 +€10,649 +256%
Trade receivables 40 €451 €42 -€409 -90.7%
Other amounts receivable 41 €3,714 €14,772 +€11,058 +298%
Cash at bank and in hand 54/58 €107,525 €65,060 -€42,466 -39.5%
Deferred charges and accrued income 490/1 €58,765 €56,000 -€2,765 -4.7%
Total equity and liabilities 10/49 €481,212 €437,107 -€44,105 -9.2%
Equity 10/15 €24,977 €51,413 +€26,436 +106%
Contributions 10/11 €10,000 €10,000 = 0.0%
Profit (loss) carried forward 14 €14,977 €41,413 +€26,436 +177%
Amounts payable 17/49 €456,235 €385,694 -€70,541 -15.5%
Amounts payable after more than one year 17 €300,847 €270,337 -€30,510 -10.1%
Financial debts 170/4 €300,847 €270,337 -€30,510 -10.1%
Amounts payable within one year 42/48 €153,888 €115,168 -€38,720 -25.2%
Current portion of amounts payable after more than one year 42 €29,525 €30,510 +€985 +3.3%
Trade debts 44 €77,690 €64,190 -€13,500 -17.4%
Suppliers 440/4 €77,690 €64,190 -€13,500 -17.4%
Taxes, remuneration and social security 45 €7,334 €1,129 -€6,205 -84.6%
Taxes 450/3 €6,254 - -€6,254
Remuneration and social security 454/9 €1,079 €1,129 +€49 +4.6%
Other amounts payable 47/48 €39,340 €19,340 -€20,000 -50.8%
Accrued charges and deferred income 492/3 €1,500 €188 -€1,312 -87.4%
Remuneration, social security and pensions 62 €7,487 €19,111 +€11,624 +155%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €13,925 €32,227 +€18,302 +131%
Other operating charges 640/8 €537 €400 -€138 -25.6%
Gross operating margin 9900 €48,991 €104,836 +€55,844 +114%
Operating profit (loss) 9901 €27,042 €53,099 +€26,056 +96.4%
Financial charges 65/66B €6,580 €19,045 +€12,465 +189%
Recurring financial charges 65 €6,580 €19,045 +€12,465 +189%
Profit (loss) for the period before taxes 9903 €20,462 €34,053 +€13,591 +66.4%
Income taxes 67/77 €5,485 €7,617 +€2,132 +38.9%
Profit (loss) for the period 9904 €14,977 €26,436 +€11,459 +76.5%
Profit (loss) for the period to be appropriated 9905 €14,977 €26,436 +€11,459 +76.5%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Value of the equity

Indication, not a valuation or advice
€39,583 to €69,163

Midpoint €51,908 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate. Change the assumptions and the value follows.

Adjusted equity -€68,735
Capitalised earnings €147,900 to €207,060
Indication €39,583 to €69,163

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€51,413
Intangible fixed assets (21)
-€120,148
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
-€68,735

Capitalised earnings

net result for the year (9904)
2025
€26,436
2024
€14,977
Average result
€20,706
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€147,900 / €172,550 / €207,060

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 21 November 2026 via checked.be.